Docoh
Loading...

MTCR Metacrine

Employees

Data from SEC filings
Employee count

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM


On May 24, 2021, Metacrine, Inc. held its 2021 annual meeting of stockholders (the “Annual Meeting”). The final results for each of the proposals submitted to a vote of the Company’s stockholders at the Annual Meeting are set forth below. The proposals set forth below are described in detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 9, 2021.

Proposal 1. The following nominees were reelected to serve on the Company’s board of directors as Class I directors until the Company’s 2024 annual meeting of stockholders, based on the following votes:

NameVotes ForVotes WithheldBroker Non-Votes
Preston Klassen, M.D.15,022,029109,5832,167,823
Jeffrey Jonker12,678,9912,452,6212,167,823
John McHutchison, M.D.14,603,473528,1392,167,823


Proposal 2. The appointment of Julia Owens, Ph.D., to the Company’s board of directors to fill a vacancy in Class III and hold office until the 2023 annual meeting of stockholders was ratified, on an advisory basis, based on the following votes:

Votes ForVotes AgainstVotes AbstainedBroker Non-Votes
15,125,4154,6971,5002,167,823


Proposal 3. The selection by the Audit Committee of the Company’s board of directors of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021 was ratified, based on the following votes:

Votes ForVotes AgainstVotes AbstainedBroker Non-Votes
17,261,85035,1802,405-